cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kura Oncology Inc
9 own
13 watching
Current Price
$19.59
$-0.4
(-2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
725.29M
52-Week High
52-Week High
22.92000
52-Week Low
52-Week Low
7.41000
Average Volume
Average Volume
0.8M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization725.29M
icon52-Week High22.92000
icon52-Week Low7.41000
iconAverage Volume0.8M
iconDividend Yield--
iconP/E Ratio--
What does the Kura Oncology Inc do?
Developing in-licensed protein inhibitors for solid tumors and blood cancers.
Read More
How much money does Kura Oncology Inc make?
News & Events about Kura Oncology Inc.
Zolmax
8 months ago
Kura Oncology, Inc. (NASDAQ:KURA Get Rating) Equities research analysts at Brookline Capital Management boosted their Q2 2023 earnings per share (EPS) estimates for shares of Kura Oncology in a research note issued to investors on Wednesday, June 14th. Brookline Capital Management analyst L. Cann ...
Globe Newswire
8 months ago
35% CR rate (7/20) among patients with relapsed/refractory NPM1-mutant AML treated at 600 mg dose (RP2D) 33% (2/6) of patients with FLT3 co-mutations and 50% (4/8) of patients with IDH co-mutations achieved a CR on ziftomenib Ziftomenib monotherapy drives durable remissions, with median DoR of 8.2 ...
Zolmax
11 months ago
Shares of Kura Oncology, Inc. (NASDAQ:KURA Get Rating) have earned a consensus recommendation of Moderate Buy from the six brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and five have issued a buy ...
Globe Newswire
11 months ago
SAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is...
Globe Newswire
1 year ago
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report fourth quarter and full year 2022 financial results ...
Frequently Asked Questions
Frequently Asked Questions
What is Kura Oncology Inc share price today?
plus_minus_icon
Can Indians buy Kura Oncology Inc shares?
plus_minus_icon
How can I buy Kura Oncology Inc shares from India?
plus_minus_icon
Can Fractional shares of Kura Oncology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kura Oncology Inc stocks?
plus_minus_icon
What is today’s traded volume of Kura Oncology Inc?
plus_minus_icon
What is today’s market capitalisation of Kura Oncology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kura Oncology Inc?
plus_minus_icon
What percentage is Kura Oncology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kura Oncology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$19.59
$-0.4
(-2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00